RNTX
Rein Therapeutics, Inc. Common Stock
RNTX
RNTX
28 hedge funds and large institutions have $8.49M invested in Rein Therapeutics, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 7 closing their positions.
Holders
28
Holders Change
-5
Holders Change %
-15.15%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
12
Reduced
9
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Jennison Associates
New York
|
$2.42M |
| 2 |
2
Millennium Management
New York
|
$151K |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$745K |
| 4 |
4
Morgan Stanley
New York
|
$144K |
| 5 |
5
State Street
Boston,
Massachusetts
|
$309K |
